These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 83086
1. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum. Tan SG, Cotterill JA, Roberts MM, Cunliffe WJ. Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086 [No Abstract] [Full Text] [Related]
8. Immunotherapy of cancer with corynebacterium parvum. Halpern B. Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374 [No Abstract] [Full Text] [Related]
14. A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results. Clunie GJ, Gough IR, Dury M, Furnival CM, Bolton PM. Cancer; 1980 Aug 01; 46(3):475-9. PubMed ID: 6994866 [Abstract] [Full Text] [Related]
17. [Comparison of the effectiveness and adverse effects of a Corynebacterium parvum vaccine made in Czechoslovakia with Coparvax, a British preparation made by Wellcome, in the treatment of malignant pleural effusions]. Marel M, Melínová L, Bednár M. Cas Lek Cesk; 1989 Aug 18; 128(34):1071-4. PubMed ID: 2790915 [Abstract] [Full Text] [Related]
18. Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma. Karakousis CP, Didolkar MS, Lopez R, Baffi R, Moore R, Holyoke ED. Cancer Treat Rep; 1979 Aug 18; 63(11-12):1739-43. PubMed ID: 393377 [Abstract] [Full Text] [Related]